| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Harmony Biosciences Holdings, Inc.'s insiders have reduced their positions by a net 72,406 shares worth roughly $3.1M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 24.5K | $907.8K | - | |
| Other | 13.1K | $485.5K | - | |
| CEO | 7.3K | $271.9K | - | |
| Other | 4.3K | $160.2K | - | |
| Other | 1.5K | $54.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Jack Nielsen76 | Director | Sell | 37,391 | $50.21 | $1,877,308.99 | -0.9% | -2.4% | -34.7% | |
| Mar 29, 2022 | Jack Nielsen76 | Director | Sell | 114,121 | $50.66 | $5,781,097.86 | -2.7% | +3.8% | -33.5% | |
| Mar 24, 2022 | Jack Nielsen76 | Director | Sell | 36,294 | $50.16 | $1,820,522.83 | -0.8% | -4.7% | -16.9% | |
| Mar 18, 2022 | Jack Nielsen76 | Director | Sell | 16,181 | $50.08 | $810,373.30 | -0.4% | -13.6% | -14.7% | |
| Mar 16, 2022 | John C Jacobs53 | President, CEO | Sale+OE | 15,000 | $45.32 | $679,821.00 | - | -6.8% | -14.2% | |
| Mar 14, 2022 | John C Jacobs53 | President, CEO | Sale+OE | 25,000 | $42.39 | $1,059,771.96 | - | +4.9% | -2.3% | |
| Mar 11, 2022 | Andreas Wicki71 | Director | Sell | 285,587 | $45.24 | $12,919,670.40 | -7.2% | +6.2% | -5.9% | |
| Mar 3, 2022 | Andreas Wicki71 | Director | Sell | 596,428 | $40.62 | $24,227,112.28 | -13.1% | +2.8% | +3.8% | |
| Mar 1, 2022 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE | 14,910 | $40.01 | $596,610.73 | - | +8.8% | +6.9% | |
| Feb 17, 2022 | Jeffrey Dierks62 | Chief Commercial Officer | Sale+OE | 8,518 | $40.03 | $341,014.72 | - | +1.7% | +25.7% |